mometasone furoate monohydrate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
RYALTRIS olopatadine 600 microgram/actuation and mometasone furoate 25 microgram/actuation nasal spray bottle AUST R: 473905Active ingredients:
mometasone furoate monohydrate
olopatadine hydrochloride
Dosage form: Spray, nasal
Sponsor: Seqirus Pty Ltd
Phone: 1800 642 865
|
From 30 Nov 2026 to 04 Jan 2027
|
Shortage status: Anticipated
Availability: Available
Reason: Unexpected increase in consumer demand
Management action: The sponsor is working to expedite the next shipment. Alternative presentation is available.
|